Survivor Story: Living with Multiple Myeloma

A survivor's story of living with multiple myeloma.

Talk about this article with other patients, caregivers, and advocates in the Myeloma CURE discussion group.
Two years prior to my cancer diagnosis, an orthopedist diagnosed me with degenerative disc disease when I went to him to help figure out what was causing excruciating lower back pain.

I was treated with pain medication and physical therapy, but my pain grew worse. After two years of treatment, an X-ray revealed several compression fractures, which ultimately led to my diagnosis of stage 3A multiple myeloma.

I have been on several chemotherapy protocols and have had a stem cell transplantation.

Although I never achieved more than a partial response to my treatments, I am confident that with continued therapy, I will someday be able to say I am cancer-free. It is also reassuring to know that there are many drugs in the pipeline for when my myeloma becomes resistant to my current therapy.

To strengthen my bones, I receive a monthly intravenous bisphosphonate; I take calcium and vitamin D supplements daily; I spend at least 15 minutes a day in the sun; I include dark leafy vegetables in my diet; and I exercise. Since my bones are fragile, I need to be careful when exercising, so I participate in an aquatics program and walk daily with my dog. My goal is to walk a half-marathon next year. I am gradually adding gentle yoga and core-strengthening exercises to my routine.

I am living a full, active life while I am in treatment. I have learned to take things one day at a time, appreciate every day and be my own health advocate.

From "A Patient's Guide to Multiple Myeloma," published in the Winter 2011 issue of CURE. Download the full guide here.

Talk about this article with other patients, caregivers, and advocates in the Myeloma CURE discussion group.
Special Feature
Share Your Art
Related Articles
Climbing Kilimanjaro for Multiple Myeloma Research Inspired More Than Just Donations
"There are not a whole lot of patients that are able to do something like this, so we were doing it for them as well," says Chuck Wakefield. "It meant so much to them to have their names on the banner."
Physician Says Ninlaro Approval Represents
In an interview with CURE, Philippe Moreau discusses the significance of Ninlaro's approval and the TOURMALINE-MM1 study.
Kyprolis Combination Approved for Relapsed Multiple Myeloma
The approval was based on findings from the phase 3 ENDEAVOR trial.
Related Videos
Blake A. Morrison Discusses the Excitement in Myeloma Research
Blake A. Morrison discusses the recent excitement in myeloma research.
Diagnosing and Treating Smoldering Multiple Myeloma
C. Ola Landgren provides an overview of the diagnosis and treatment of smoldering multiple myeloma.
Measuring Response to Treatment in Multiple Myeloma
C. Ola Landgren discusses ways to measure response to treatment in multiple myeloma.